Found: 15
Select item for more details and to access through your institution.
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
- Published in:
- 2021
- By:
- Publication type:
- journal article
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 3, p. 482, doi. 10.3390/jpm13030482
- By:
- Publication type:
- Article
Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29684-9
- By:
- Publication type:
- Article
MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27921-1
- By:
- Publication type:
- Article
PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma.
- Published in:
- Scientific Reports, 2016, p. 39630, doi. 10.1038/srep39630
- By:
- Publication type:
- Article
Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients.
- Published in:
- Bioscience Reports, 2023, v. 43, n. 2, p. 1, doi. 10.1042/BSR20221659
- By:
- Publication type:
- Article
Integrative bioinformatic analysis identified IFIT3 as a novel regulatory factor in psoriasis.
- Published in:
- Journal of Cellular Biochemistry, 2022, v. 123, n. 12, p. 2066, doi. 10.1002/jcb.30332
- By:
- Publication type:
- Article
MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0357-4
- By:
- Publication type:
- Article
Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 12, p. 3709, doi. 10.7150/ijbs.84577
- By:
- Publication type:
- Article
IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 6, p. 1, doi. 10.1038/s41419-024-06843-y
- By:
- Publication type:
- Article
Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41419-022-04514-4
- By:
- Publication type:
- Article
SH2B1 promotes epithelial‐mesenchymal transition through the IRS1/β‐catenin signaling axis in lung adenocarcinoma.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 5, p. 640, doi. 10.1002/mc.22788
- By:
- Publication type:
- Article
PSMA1, a Poor Prognostic Factor, Promotes Tumor Growth in Lung Squamous Cell Carcinoma.
- Published in:
- Disease Markers, 2023, p. 1, doi. 10.1155/2023/5386635
- By:
- Publication type:
- Article
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade.
- Published in:
- Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0632-x
- By:
- Publication type:
- Article